Nebius H100 price hikes reinforce near-term pricing power, but WAIT rating stands as valuation already prices smooth execution

What happened

Nebius is reportedly raising prices on even four-year-old H100 GPUs, a move that contradicts any AI demand slowdown and supports the company's Q2 disclosure that older-generation GPU pricing rose more than 30% sequentially. The article frames this as evidence that Nebius and neocloud peers retain pricing power in the short term, especially with Nvidia's Vera Rubin generation upcoming. While the news reinforces the near-term revenue and EBITDA upside embedded in our base case, it does not alter our WAIT rating because the stock already trades at $226.4, or 113.9x EV/EBITDA, and has no margin of safety. Execution risk remains centered on converting contracted power into live capacity on schedule, particularly the early-2027 Meta ramp and the up to $15 billion of incremental Meta-linked capacity that must be placed with third parties first. The price hikes are a positive data point but not a thesis changer; they confirm scarcity-driven pricing, which our bull scenario already assumes, while the bear case still hinges on commissioning delays and financing slippage.

Implication

Investors should view the reported H100 price increases as confirmation that AI compute demand remains tight, but not as a reason to chase the stock at $226.4, where valuation already embeds successful 2027 capacity expansion. The key risk remains execution: if late-2026 deployments slip or the Meta dedicated capacity does not start on time in early 2027, revenue conversion and financing terms could deteriorate simultaneously. Conversely, if Nebius confirms the Q4 2026 premium capacity deal went live, prepayments track above $9 billion, and no service credits emerge by March 2027, the bull case gains credibility. Until then, the asymmetric risk-reward is absent, and any position should be sized with the understanding that downside protection depends on delivery, not asset backing. The most attractive entry remains around $185, while a break above $270 would signal the market is overpaying for execution that hasn't happened yet.

Thesis delta

The new article does not materially shift our thesis. It provides incremental evidence of pricing power, consistent with the Q2 disclosure that older-gen GPU pricing rose over 30% and deals averaged above $20M ACV per MW. The WAIT rating and valuation concerns remain unchanged; the news reinforces the bull case's pricing assumption but does not address execution or financing risks that dominate the bear case.